Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−12.5865USD
−9.32 MUSD
11.53 M
About Tharimmune, Inc.
Sector
Industry
CEO
Randy D. Milby
Website
Headquarters
Bridgewater
Employees (FY)
2
Founded
2017
FIGI
BBG012QFR2V4
Tharimmune, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure. The company was founded on March 28, 2017 and is headquartered in Bridgewater, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of THAR is 0.3700 USD — it has increased by 1.90% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tharimmune, Inc. stocks are traded under the ticker THAR.
Tharimmune, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
THAR stock is 1.90% volatile and has beta coefficient of 0.10. Check out the list of the most volatile stocks — is Tharimmune, Inc. there?
THAR earnings for the last quarter are −0.11 USD per share, whereas the estimation was −1.25 USD resulting in a 91.20% surprise. The estimated earnings for the next quarter are −1.00 USD per share. See more details about Tharimmune, Inc. earnings.
Yes, you can track Tharimmune, Inc. financials in yearly and quarterly reports right on TradingView.
THAR stock has fallen by 0.86% compared to the previous week, the month change is a 15.70% fall, over the last year Tharimmune, Inc. has showed a 96.62% decrease.
THAR net income for the last quarter is −2.47 M USD, while the quarter before that showed −1.82 M USD of net income which accounts for −35.91% change. Track more Tharimmune, Inc. financial stats to get the full picture.
No, THAR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, THAR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tharimmune, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of May 1, 2024, the company has 2.00 employees. See our rating of the largest employees — is Tharimmune, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tharimmune, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tharimmune, Inc. stock shows the sell signal. See more of Tharimmune, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Tharimmune, Inc. future price: according to them, THAR price has a max estimate of 125.00 USD and a min estimate of 125.00 USD. Read a more detailed Tharimmune, Inc. forecast: see what analysts think of Tharimmune, Inc. and suggest that you do with its stocks.